Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
Authors:
Open Access
- 14 February 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 772615
Abstract
Triple negative breast cancer (TNBC) refers to the subtype of breast cancer which is negative for ER, PR, and HER-2 receptors. Tumor-associated macrophages (TAMs) refer to the leukocyte infiltrating tumor, derived from circulating blood mononuclear cells and differentiating into macrophages after exuding tissues. TAMs are divided into typical activated M1 subtype and alternately activated M2 subtype, which have different expressions of receptors, cytokines and chemokines. M1 is characterized by expressing a large amount of inducible nitric oxide synthase and TNF-α, and exert anti-tumor activity by promoting pro-inflammatory and immune responses. M2 usually expresses Arginase 1 and high levels of cytokines, growth factors and proteases to support their carcinogenic function. Recent studies demonstrate that TAMs participate in the process of TNBC from occurrence to metastasis, and might serve as potential biomarkers for prognosis prediction.Keywords
This publication has 132 references indexed in Scilit:
- The role of tumor-associated macrophages in breast cancer progressionInternational Journal of Oncology, 2013
- Tumor-associated macrophages: functional diversity, clinical significance, and open questionsSeminars in Immunopathology, 2013
- Anti‐tumour strategies aiming to target tumour‐associated macrophagesImmunology, 2013
- The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated MacrophagesBioMed Research International, 2012
- Bisphosphonate Use and the Risk of Breast Cancer: A Meta-Analysis of Published LiteratureClinical Breast Cancer, 2012
- Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agentsAnnals of Oncology, 2012
- Behavior of seeds and soil in the mechanism of metastasis: A deeper understandingCancer Science, 2012
- Tumour macrophages as potential targets of bisphosphonatesJournal of Translational Medicine, 2011
- LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40LBlood, 2011
- Role of macrophages in tumour progressionImmunology Letters, 2009